Paradigm Biopharmaceuticals Limited (PAR.AU) Q1 2024 Earnings

28FebConfirmed
Oct 22
Q4 2022
Q2 2023
Q1 2024
-0.17
0.16
0.5
0.83

Details

Expected EPS
N/A
Actual EPS
-0.1711750900748314
Surprise EPS
-0.17
Surprise Percent
+∞%

Description

Paradigm Biopharmaceuticals Limited (PAR.AU) has reported earnings of -0.1711750900748314 per share for Q1 2024.

0 Comments

Share your thoughts